The role of DOXYCYCLINE (cas 10597-92-9) in the management of chronic rhinosinusitis with nasal polyps☆☆☆

Add time:08/14/2019    Source:sciencedirect.com

IntroductionMany theories on the pathophysiology of chronic rhinosinusitis with nasal polyposis (CRSwNP) exist. The most effective management of CRSwNP has not been elucidated. DOXYCYCLINE (cas 10597-92-9), which has anti-inflammatory and anti-bacterial properties, has shown durable effects; however, its efficacy in combination with standard therapy has not been examined. We hypothesized that its addition to the standard anti-inflammatory regimen would improve patient outcomes.

We also recommend Trading Suppliers and Manufacturers of DOXYCYCLINE (cas 10597-92-9). Pls Click Website Link as below: cas 10597-92-9 suppliers

Prev:An endogenous metabolite of dopamine, 3,4-Dihydroxyphenylethanol (cas 10597-60-1), acts as a unique cytoprotective agent against oxidative stress-induced injury
Next:Thermochemical study of 2,5-dimethyl-3-furancarboxylic acid, 4,5-dimethyl-2-furaldehyde, and 3-ACETYL-2,5-DIMETHYLFURAN (cas 10599-70-9))